Efficacy of anti-TNF therapies in refractory severe microscopic colitis

Journal of Crohn's and Colitis

Volumn 5, Issue 6, 2011, Pages 612-618

  Esteve, Maria ^a   Mahadevan, Uma ^b   Sainz, Empar ^a   Rodriguez, Elena ^b   Salas, Antonio ^a   Fernández Bañares, Fernando ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti TNF agents; Collagenous colitis; Microscopic colitis

Indexed keywords

ADALIMUMAB; HLA DQ2 ANTIGEN; INFLIXIMAB; SULFANILAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; COLON RESECTION; DATA BASE; DISEASE SEVERITY; DRUG SUBSTITUTION; FEMALE; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTESTINE MOTILITY; LONG TERM CARE; LYMPHOCYTIC COLITIS; PRIORITY JOURNAL; PRURITUS; REMISSION; STEVENS JOHNSON SYNDROME; SYMPTOM; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTORS;

EID: 82255191888     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.05.001     Document Type: Article

References (17)

1. Fernández-Bañares F., Salas A., Esteve M., Pardo L., Casalots J., Forné M., Espinós J.C., Loras C., Rosinach M., Viver J.M. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis Sep. 27 2010, Pubmed PMID: 20878755.
2. Tysk C., Bohr J., Nyhlin N., Wickbom A., Eriksson S. Diagnosis and management of microscopic colitis. World J Gastroenterol 2008, 14(48):7280-7288.
3. Pardi D.S., Loftus E.V., Tremaine W.J., Sandborn W.J. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001, 120:1483-1484.
4. Vennamaneni S.R., Bonner G.F. Use of azathioprine or 6-mercaptopurine for treatment of steroid-dependent lymphocytic and collagenous colitis. Am J Gastroenterol 2001, 96:2798-2799.
5. Riddell J., Hillman L., Chiragakis L., Clarke A. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol 2007, 22:1589-1593.
6. Fernández-Bañares F., Esteve M., Espinós J.C., Rosinach M., Forné M., Salas A., Viver J.M. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007, 102:324-330.
7. Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121:255-260.
8. Limsui D., Pardi D.S., Camilleri M., Loftus E.V., Kammer P.P., Tremaine W.J., Sandborn W.J. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007, 13:175-181.
9. Fernández-Bañares F., Salas A., Esteve M. Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis. J Crohns Colitis 2008, 2:343-347.
10. Janczewska I., Mejhert M., Hast R., Runarsson G., Sandstedt B. Primary AL-amyloidosis, ulcerative colitis and collagenous colitis in a 57-year-old woman: a case study. Scand J Gastroenterol 2004, 39:1306-1309.
11. Ebert E.C., Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 2008, 103:776-787.
12. Serra I., Oller B., Mañosa M., Naves J.E., Zabana Y., Cabré E., Domènech E. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome. J Crohns Colitis 2010, 4:269-274.
13. Park Y.K., Han D.S., Eun C.S. Systemic amyloidosis with Crohn's disease treated with infliximab. Inflamm Bowel Dis 2008, 14:431-432.
14. Shen B., Bennett A.E., Fazio V.W., Sherman K.K., Sun J., Remzi F.H., Lashner B.A. Collagenous pouchitis. Dig Liver Dis 2006, 38:704-709.
15. Miehlke S., Heymer P., Bethke B., Bästlein E., Meier E., Bartram H.P., Wilhelms G., Lehn N., Dorta G., DeLarive J., Tromm A., Bayerdörffer E., Stolte M. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002, 123:978-984.
16. Baert F., Schmit A., D'Haens G., Dedeurwaerdere F., Louis E., Cabooter M., De Vos M., Fontaine F., Naegels S., Schurmans P., Stals H., Geboes K., Rutgeerts P. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002, 122:20-25. Belgian IBD Research Group, Codali BrusselsCodali Brussels.
17. Fernández-Bañares F., Salas A., Esteve M., Espinós J., Forné M., Viver J.M. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003, 98:340-347.